Invitrogen™ Human LYRM1 Synthetic Peptide

Catalog No.	Quantity
PEP1034	50 μg

Catalog No. PEP1034 Supplier Invitrogen™ Supplier No. PEP1034

Description

Synthetic Peptide

LYRM1 Synthetic Peptide, PEP-1034, from Invitrogen.

LYRM1 was one of many genes identified through a suppression subtractive hybridization comparing their expression in omental adipose tissue of obese patients compared to non-obese individuals. Further study confirms that both mRNA and protein levels of LYRM1 are higher in obese individuals. LYRM1 is widely expressed, with highest levels occurring in adipose and liver tissues. It is thought that LYRM1 promotes preadipocyte proliferation and can inhibit apoptosis of preadipocytes. Ectopic LYRM1 expression did not significantly affect adipogenesis, suggesting that LYRM1 can influence adipose tissue homeostasis by modulating the size of the preadipocyte pool.

Specifications

• Gene ID (Entrez): 57149
• Species: Human
• Purification Method: purified
• Accession Number: O43325
• Common Name: Human LYRM1
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: LYRM1
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS